Breakout Stocks of Week 27 @ NYSE

NASDAQ was down last week (week 26) by -4.60% ending at 25,297.62 points after falling -1,220.31 points during the week. Our system has detected some possible breakout stocks for the following week and these should be on your watchlist. These are the stocks that are bouncing up with good increase in volume and are likely to do good in short term. One of these stocks are AMN Healthcare Services, Inc. NYSE:AMN. This stock has had a buy signal since Apr 27, 2026 when the price was $20.98 and is so far up 56.15% to $32.76. Some other companies are on our watchlist to, among these are Nextdoor Holdings, Inc. NYSE:NXDR Internationa Flavors & Fragrances Inc NYSE:IFF Organon & Co. NYSE:OGN and Genco Shipping & Trading Limited Warrants Expiring 12/31/2021 NYSE:GNK which all got a breakout pattern emerging.

Date Company Price Week 27
Jun 26, 2026 Amn Healthcare Services, Inc. $32.76 $34.75 6.07%
Jun 26, 2026 Nextdoor Holdings, Inc. $2.22 $2.29 3.15%
Jun 26, 2026 Internationa Flavors & Fragrances Inc $76.35 $83.83 9.80%
Jun 26, 2026 Organon & Co. $13.50 $13.55 0.370%
Jun 26, 2026 Genco Shipping & Trading Limited Warrants Expiring... $23.57 $24.50 3.95%

AMN Healthcare Services, Inc.

NYSE:AMN Strong Buy Candidate Score: 7.92
Strong Buy Candidate Score: 7.92 Jun 26, 2026

AMN Healthcare Services, Inc.The AMN Healthcare Services, Inc. stock price gained 1.33% on the last trading day (Friday, 26th Jun 2026), rising from $32.33 to $32.76. It has now gained 4 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 4.95% from a day low at $31.90 to a day high of $33.48. The price has risen in 8 of the last 10 days and is up by 6.4% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 201 thousand more shares were traded than the day before. In total, 991 thousand shares were bought and sold for approximately $32.47 million.

On Jun 23, 2026, it was reported that Citigroup gave AMN a "Market Outperform" grade with a "hold" action.

AMN Healthcare Services, Inc. holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months.

About AMN Healthcare Services, Inc.:
AMN Healthcare Services, Inc. provides healthcare workforce solutions and staffing services to hospitals and healthcare facilities in the United States. It operates through three segments: Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions. The Nurse and Allied Solutions segment offers travel nurse staffing, rapid response nurse staffing and labor disruption, allied staffing, local staffing, and revenue cycle solutions. The Physician and Leadership Solutions segment provides locum tenens staffing, healthcare interim leadership staffing, executive search, and physician permanent placement solutions. The Technology and Workforce Solutions segment offers language services, vendor management systems, workforce optimization, telehealth, credentialing, and outsourced solutions. The company also provides allied health professionals, such as physical therapists, respiratory therapists, occupational therapists, medical and radiology technologists, lab technicians, speech pathologists, rehabilitation assistants, and pharmacists. It offers its services under the brands, including American Mobile, Nursefinders, NurseChoice, HealthSource Global Staffing, Onward Healthcare, O'Grady Peyton International, Med Travelers, Club Staffing, Staff Care, B.E. Smith, and Merritt Hawkins, as well as AMN Revenue Cycle Solutions and AMN Language Services. The company was founded in 1985 and is based in Dallas, Texas.

Nextdoor Holdings, Inc.

NYSE:NXDR Strong Buy Candidate Score: 6.93
Strong Buy Candidate Score: 6.93 Jun 26, 2026

The Nextdoor Holdings, Inc. stock price gained 4.72% on the last trading day (Friday, 26th Jun 2026), rising from $2.12 to $2.22. During the last trading day the stock fluctuated 6.43% from a day low at $2.10 to a day high of $2.24. The price has been going up and down for this period, and there has been a 3.74% gain for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 2 million more shares were traded than the day before. In total, 4 million shares were bought and sold for approximately $9.44 million.

On May 07, 2026, it was reported that Goldman Sachs gave NXDR a "Neutral" grade with a "hold" action.

Nextdoor Holdings, Inc. holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months.

Internationa Flavors & Fragrances Inc

NYSE:IFF Buy Candidate Score: 4.66
Buy Candidate Score: 4.66 Jun 26, 2026

Internationa Flavors & Fragrances IncThe Internationa Flavors & Fragrances Inc stock price gained 1.69% on the last trading day (Friday, 26th Jun 2026), rising from $75.08 to $76.35. During the last trading day the stock fluctuated 3.05% from a day low at $74.09 to a day high of $76.35. The price has been going up and down for this period, and there has been a -1.5% loss for the last 2 weeks. Volume fell on the last day by -157 thousand shares and in total, 968 thousand shares were bought and sold for approximately $73.92 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

On Jul 01, 2026, it was reported that Morgan Stanley gave IFF a "Overweight" grade with a "hold" action.

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Internationa Flavors & Fragrances Inc stock to perform well in the short-term.

About Internationa Flavors & Fragrances Inc:
International Flavors & Fragrances Inc., together with its subsidiaries, manufactures and sells cosmetic active and natural health ingredients for use in various consumer products in Europe, Africa, the Middle East, Greater Asia, North America, and Latin America. It operates through Nourish, Scent, Health & Biosciences, and Pharma Solutions segments. The Nourish segment offers natural and plant-based specialty food ingredients, such as flavor compounds, and savory solutions and inclusions. It also provides natural food protection ingredients consist of natural antioxidants and anti-microbials as well as beverages, sweets , and dairy products. The Scent segment provides fragrance compounds, which include fine fragrances comprising perfumes and colognes, as well as consumer fragrances; fragrance ingredients comprising synthetic and natural ingredients that could be combined with other materials to create fragrance and consumer compounds; and cosmetic active ingredients consisting of active and functional ingredients, botanicals, and delivery systems to support its customers' cosmetic and personal care product lines. The Health & Biosciences segment develops and produces enzymes, food cultures, probiotics, and specialty ingredients. The Pharma Solutions segment produces and sells cellulosics and seaweed-based pharma excipients. The company sells its products primarily to manufacturers of perfumes and cosmetics, hair and other personal care products, soaps and detergents, cleaning products, dairy, meat and other processed foods, beverages, snacks and savory foods, sweet and baked goods, dietary supplements, infant and elderly nutrition, functional food, and pharmaceutical excipients and oral care products. International Flavors & Fragrances Inc. was founded in 1833 and is headquartered in New York, New York.

Organon & Co.

NYSE:OGN Buy Candidate Score: 4.60
Buy Candidate Score: 4.60 Jun 26, 2026

Organon & Co.The Organon & Co. stock price gained 0.223% on the last trading day (Friday, 26th Jun 2026), rising from $13.47 to $13.50. During the last trading day the stock fluctuated 0.557% from a day low at $13.46 to a day high of $13.54. The price has been going up and down for this period, and there has been a 0.37% gain for the last 2 weeks. Volume fell on the last day by -113 thousand shares and in total, 926 thousand shares were bought and sold for approximately $12.50 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

On Apr 27, 2026, it was reported that Piper Sandler gave OGN a "Neutral" grade with a "upgrade" action.

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Organon & Co. stock to perform well in the short-term.

About Organon & Co.:
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio consists of three immunology products, such as Brenzys, Renflexis, and Hadlima, as well as two oncology products, including Ontruzant and Aybintio. It also offers cardiovascular products, consisting of several cholesterol-modifying medicines under the Zetia, Ezetrol, Vytorin, Inegy, Rosuzet, and Zocor brands; Cozaar and Hyzaar for the treatment of hypertension; respiratory products for various treatments to control and prevent symptoms caused by asthma under the Singulair, Dulera, Zenhale, and Asmanex brand names; and Singulair, Nasonex, Clarinex, and Aerius for treating seasonal allergic rhinitis. In addition, the company provides dermatology products under the Diprosone and Elocon brand; bone health portfolio, including Fosamax brand name; non-opioid pain management products under the Arcoxia, Diprospan, and Celestone brand names; Proscar for the treatment of symptomatic benign prostatic hyperplasia; and Propecia for the treatment of male pattern hair loss. The company sells its products primarily to drug wholesalers and retailers, hospitals, and government agencies, as well as managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions. Organon & Co. was incorporated in 2020 and is based in Jersey City, New Jersey.

Genco Shipping & Trading Limited Warrants Expiring 12/31/2021

NYSE:GNK Buy Candidate Score: 2.38
Buy Candidate Score: 2.38 Jun 26, 2026

Genco Shipping & Trading Limited Warrants Expiring 12/31/2021The Genco Shipping & Trading Ltd Warrants stock price gained 0.512% on the last trading day (Friday, 26th Jun 2026), rising from $23.45 to $23.57. During the last trading day the stock fluctuated 3.79% from a day low at $22.93 to a day high of $23.80. The price has fallen in 6 of the last 10 days and is down by -0.51% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 319 thousand more shares were traded than the day before. In total, 518 thousand shares were bought and sold for approximately $12.22 million.

On Jun 17, 2026, it was reported that Alliance Global Partners gave GNK a "Neutral" grade with a "hold" action.

Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as there is a fair chance for Genco Shipping & Trading Ltd Warrants stock to perform well in the short-term period.

About Genco Shipping & Trading Limited Warrants Expiring 12/31/2021:
Genco Shipping & Trading Limited, together with its subsidiaries, engages in the ocean transportation of dry bulk cargoes worldwide. The company owns and operates dry bulk carrier vessels to transports iron ore, coal, grains, steel products, and other dry-bulk cargoes. It charters its vessels primarily to trading houses, including commodities traders; producers; and government-owned entities. As of December 31, 2021, the company fleet consisted of 44 dry bulk carriers, including 17 Capesize, 15 Ultramax, and 12 Supramax with an aggregate capacity of approximately 4,636,000 deadweight tons. Genco Shipping & Trading Limited was incorporated in 2004 and is headquartered in New York, New York.

GOLDEN STAR
Ticker Change Signal Date
FOX
$50.81
2.22% Jul 27
UNFI
$49.05
3.63% Jul 27
BIIB
$202.19
0.376% Jul 24
TSCO
$30.32
1.48% Jul 23
S
SW
$43.71
5.17% Jul 23
.

StockInvest.usStock Podcast